INVICTUS ONCOLOGY
Founders: Dr. Raghunath Mashelkar & Dr. Shiladitya Sengupta
Headquarters: Delhi, India
Year Founded: 2011
Year Romulus Invested: 2017
Invictus Oncology is a biotechnology company pioneering exciting new types of cancer solutions, particularly focused at present on Triple Negative Breast Cancer (TNBC). The company aims to adopt a multidisciplinary approach to research, with the ultimate goal of a paradigm shift in cancer care.
The Invictus-Romulus story:
We became familiar with Invictus through our relationship with co-founder Shiladitya Sengupta, who also co-founded Vyome Biosciences, another company in which we have invested.